Year
2023
-
Teva, MedinCell win FDA approval for slow-release schizophrenia drug Uzedy
-
With FDA nod for Lumryz, Avadel is set to Jazz up the narcolepsy market
-
Alzheimer’s drug developed by Lilly slows cognitive decline by 35 pct
-
Merck agrees to build bioprocessing production plant in South Korea
-
FDA Approves First-Ever RSV Vaccine After Brutal 2022 Season
-
Vertex secures FDA clearance for infants’ cystic fibrosis therapy
-
Boehringer Ingelheim Earns Breakthrough Therapy Designation for Pustular Psoriasis Drug
-
Cognixion receives FDA Breakthrough Device Designation for assisted communication device
-
ChemDiv’s library in significant research
-
For supplier. Chemical vendors.